Literature DB >> 27765542

Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.

Kemal Ekici1, Eda K Pepele2, Bahaddin Yaprak2, Oztun Temelli2, Aysun F Eraslan2, Nadir Kucuk3, Ayse Y Altınok3, Pelin A Sut4, Ozlem D Alpak4, Cemil Colak5, Alpaslan Mayadagli4.   

Abstract

Various radiotherapy planning methods for T1N0 laryngeal cancer have been proposed to decrease normal tissue toxicity. We compare helical tomotherapy (HT), linac-based intensity-modulated radiation therapy (IMRT), volumetric-modulated arc therapy (VMAT), and 3-D conformal radiotherapy (3D-CRT) techniques for T1N0 laryngeal cancer. Overall, 10 patients with T1N0 laryngeal cancer were selected and evaluated. Furthermore, 10 radiotherapy treatment plans have been created for all 10 patients, including HT, IMRT, VMAT, and 3D-CRT. IMRT, VMAT, and HT plans vs 3D-CRT plans consistently provided superior planning target volume (PTV) coverage. Similar target coverage was observed between the 3 IMRT modalities. Compared with 3D-CRT, IMRT, HT, and VMAT significantly reduced the mean dose to the carotid arteries. VMAT resulted in the lowest mean dose to the submandibular and thyroid glands. Compared with 3D-CRT, IMRT, HT, and VMAT significantly increased the maximum dose to the spinal cord It was observed that the 3 IMRT modalities studied showed superior target coverage with less variation between each plan in comparison with 3D-CRT. The 3D-CRT plans performed better at the Dmax of the spinal cord. Clinical investigation is warranted to determine if these treatment approaches would translate into a reduction in radiation therapy-induced toxicities.
Copyright © 2016 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Helical tomotherapy; Intensity-modulated radiotherapy; Larynx cancer; Volumetric arc therapy

Mesh:

Year:  2016        PMID: 27765542     DOI: 10.1016/j.meddos.2016.08.002

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  2 in total

1.  Report on planning comparison of VMAT, IMRT and helical tomotherapy for the ESCALOX-trial pre-study.

Authors:  Steffi U Pigorsch; Severin Kampfer; Markus Oechsner; Michael C Mayinger; Petra Mozes; Michal Devecka; Kerstin K Kessel; Stephanie E Combs; Jan J Wilkens
Journal:  Radiat Oncol       Date:  2020-11-02       Impact factor: 3.481

2.  Dosimetric Comparisons of Volumetric Modulated Arc Therapy and Tomotherapy for Early T-Stage Nasopharyngeal Carcinoma.

Authors:  Shan Li; Qin Zhou; Liang-Fang Shen; Huan Li; Zhan-Zhan Li; Zhen Yang; Ming-Jun Lei; Xiao-Yu Yang; Zi-Jian Zhang; Yong-Mei Hu; Ze-Fu Jin; Gui Liu; Zhi-Ping Lv; Xin-Qiong Huang
Journal:  Biomed Res Int       Date:  2018-06-04       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.